CN100340287C - 防止uvb引起的皮肤损伤的方法 - Google Patents

防止uvb引起的皮肤损伤的方法 Download PDF

Info

Publication number
CN100340287C
CN100340287C CNB028112849A CN02811284A CN100340287C CN 100340287 C CN100340287 C CN 100340287C CN B028112849 A CNB028112849 A CN B028112849A CN 02811284 A CN02811284 A CN 02811284A CN 100340287 C CN100340287 C CN 100340287C
Authority
CN
China
Prior art keywords
tsp
cells
uvb
skin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB028112849A
Other languages
English (en)
Chinese (zh)
Other versions
CN1512868A (zh
Inventor
迈克尔·J·德特马
矢野喜一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of CN1512868A publication Critical patent/CN1512868A/zh
Application granted granted Critical
Publication of CN100340287C publication Critical patent/CN100340287C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB028112849A 2001-04-13 2002-04-11 防止uvb引起的皮肤损伤的方法 Expired - Lifetime CN100340287C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
US60/283,874 2001-04-13

Publications (2)

Publication Number Publication Date
CN1512868A CN1512868A (zh) 2004-07-14
CN100340287C true CN100340287C (zh) 2007-10-03

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028112849A Expired - Lifetime CN100340287C (zh) 2001-04-13 2002-04-11 防止uvb引起的皮肤损伤的方法

Country Status (8)

Country Link
US (1) US6712617B2 (https=)
EP (1) EP1377253A4 (https=)
JP (1) JP2004526758A (https=)
KR (2) KR20040021598A (https=)
CN (1) CN100340287C (https=)
CA (1) CA2446093A1 (https=)
TW (1) TWI233361B (https=)
WO (1) WO2002083088A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
EP1559429A4 (en) * 2002-06-25 2009-09-09 Shiseido Co Ltd AGAIN AGING AGING
CA2494536C (en) * 2002-07-31 2011-10-04 Mercian Corporation A 12-membered ring macrolide active substance
JP4459051B2 (ja) * 2002-07-31 2010-04-28 メルシャン株式会社 新規生理活性物質
US7458982B2 (en) 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
BR0316746A (pt) * 2002-11-29 2005-10-18 Mercian Corp Método de produção do composto macrolida 11107d, linhagem streptomyces sp.ab-1704 (ferm bp-8551), linhagem mortierella sp. f1529 (ferm bp-8547) ou linhagem f-1530 (ferm bp-8548), e linhagem ab-1896 (ferm bp-8550)
US20050281761A1 (en) * 2004-04-01 2005-12-22 Michael Detmar Methods of preventing UVB-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006042114A1 (en) * 2004-10-06 2006-04-20 Cook, Inc. Emboli capturing device having a coil and method for capturing emboli
EP3340511B1 (en) 2004-10-12 2022-11-30 TQ Delta, LLC Resource sharing in a telecommunications enviroment
US9084734B2 (en) 2005-05-05 2015-07-21 Danisco Us Inc. Peptide personal care compositions and methods for their use
EP1938827A4 (en) * 2005-09-16 2010-07-21 Shiseido Co Ltd NEW HEMMER OF THE EXPRESSION OF VASCULAR ENDOTHEL GROWTH FACTOR
TWI428143B (zh) 2006-01-18 2014-03-01 Gen Hospital Corp 增加淋巴功能之方法
AU2007257055A1 (en) 2006-04-12 2007-12-13 Aware, Inc. Packet retransmission and memory sharing
WO2008005533A2 (en) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
WO2008020584A1 (en) * 2006-08-14 2008-02-21 Eisai R & D Management Co., Ltd. Stable lyophilized preparation
US7790887B2 (en) * 2007-01-29 2010-09-07 Eisai R&D Management Co., Ltd. Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same
CN101970012A (zh) 2007-09-14 2011-02-09 日东电工株式会社 药物载体
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
US20240189397A1 (en) * 2019-12-24 2024-06-13 Juvena Therapeutics, Inc. Heparin-Associated Polypeptides and Uses Thereof
CN115379850A (zh) 2019-12-24 2022-11-22 裘美娜治疗公司 再生性多肽及其用途
WO2022271466A1 (en) 2021-06-21 2022-12-29 Juvena Therapeutics, Inc. Regenerative polypeptides and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1258198A (zh) * 1997-05-27 2000-06-28 塞姆柏奥希斯遗传学公司 油体的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
WO1999026649A1 (en) * 1997-11-25 1999-06-03 Cornell Research Foundation, Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
EP1171151A4 (en) * 1999-03-31 2004-08-04 Gen Hospital Corp THROMBOSPONDIN-2 AND THEIR USE
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1258198A (zh) * 1997-05-27 2000-06-28 塞姆柏奥希斯遗传学公司 油体的用途

Also Published As

Publication number Publication date
US6712617B2 (en) 2004-03-30
TWI233361B (en) 2005-06-01
KR20040021598A (ko) 2004-03-10
WO2002083088A1 (en) 2002-10-24
US20030008821A1 (en) 2003-01-09
JP2004526758A (ja) 2004-09-02
CN1512868A (zh) 2004-07-14
EP1377253A1 (en) 2004-01-07
EP1377253A4 (en) 2008-09-03
KR20080108366A (ko) 2008-12-12
CA2446093A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
CN100340287C (zh) 防止uvb引起的皮肤损伤的方法
JP5960749B2 (ja) 毛の成長を調節する方法
US6773881B2 (en) Methods of modulating hair growth
EP1311277A1 (en) Methods of modulating fibrosis
Haze et al. Regeneration of bone and periodontal ligament induced by recombinant amelogenin after periodontitis
Arend et al. Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice
US20080311083A1 (en) Methods of Modulating Beta Cell Function
CN101277672A (zh) 用于减少皮肤损伤的方法和组合物
CN1622797A (zh) 利用肌动蛋白结合肽促进毛发生长的方法和组合物
KR20070046064A (ko) 피부 손상 방지
US20020048581A1 (en) Modulation of nitric oxide synthase by PKC
JP2003505471A (ja) Vgfポリペプチドおよびvgf関連障害の治療方法
US20030211109A1 (en) Methods of modulating angiogenesis
AU2002254588B2 (en) Methods of Preventing UVB-Induced Skin Damage
AU2002254588A1 (en) Methods of Preventing UVB-Induced Skin Damage
US6759201B2 (en) Method of identifying a neural progenitor cell by evaluating expression of daedalos
Fenjves et al. Prospects for epithelial gene therapy
US20050136039A1 (en) Adipocytes and uses thereof
CN104888221B (zh) 一种治疗皮肤萎缩相关疾病的药物作用靶点
Hofmann et al. Anatomy and Embryology of the Thymus
HK1038886A1 (en) USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF KIDNEY DISORDER
TW200418979A (en) Physiologically active polypeptide and its antibody and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20071003